Howard Fine

Howard Fine is a leading glioblastoma researcher who has characterized glioma stem cells and their role in driving tumor recurrence and therapeutic resistance. His laboratory investigates the molecular mechanisms maintaining glioblastoma stem cell self-renewal and explores novel therapeutic approaches targeting these cells. He has contributed to understanding the immunosuppressive tumor microenvironment in glioblastoma and strategies to enhance immunotherapy efficacy. He has led multiple clinical trials testing novel agents in glioblastoma patients.